Table 4.

The correlations of SDU-P (planned procedures) and SDU-D (delivered procedures) with auxiliary test results, including blood tests, used in the assessment of MetS components. # Spearman’s correlation, ˅ general linear model.

		SDU-P (Planned Procedures)				SDU-D (Delivered Procedures)
Parameter	N	Mean ± SD	Spearman’s rho Coefficient #	p Value	OR and 95% CI ˅	Spearman’s rho Coefficient #	p Value	OR and 95% CI ˅
Weight (kilograms)	66,617	72.2 ± 31.7	0.105	<0.001	1.008 (1.007–1.010)	0.05	<0.001	1.002 (1.001–1.003)
Body mass index (BMI)	66,617	24.1 ± 4.5	0.129	<0.001	1.167 (1.157–1.178)	0.061	<0.001	1.057 (1.050–1.065)
C-reactive protein (CRP) (mg/L)	43,081	3.8 ± 10.1	0.085	<0.001	1.008 (1.002–1.014)	0.051	<0.001	1.005 (1.001–1.008)
Glycated hemoglobin (HbA1c) (%)	2832	5.4 ± 0.9	0.168	<0.001	2.558 (1.733–3.775)	0.048	0.033	1.324 (1.106–1.585)
Fasting glucose (mg/dL)	2927	87.1 ± 11.9	0.059	0.030	1.047 (1.016–1.080)	0.052	0.008	1.020 (1.005–1.035)
Cholesterol (mg/dL)	39,472	175.7 ± 35.9	0.096	<0.001	1.019 (1.016–1.021)	0.030	<0.001	1.003 (1.002–1.005)
High-density lipoprotein (HDL) (mg/dL)	39,453	48.5 ± 11.9	−0.084	<0.001	0.955 (0.949–0.962)	−0.087	<0.001	0.972 (0.969–0.976)
Low-density lipoprotein (LDL) (mg/dL)	25,371	108.6 ± 30.2	0.1	<0.001	1.024 (1.020–1.027)	0.044	<0.001	1.006 (1.004–1.008)
LDL cholesterol calculated (mg/dL)	25,324	107.3 ± 30.6	0.126	<0.001	1.025 (1.022–1.029)	0.047	<0.001	1.006 (1.004–1.008)
Triglycerides (mg/dL)	39,482	104.5 ± 64.1	0.091	<0.001	1.009 (1.008–1.011)	0.062	<0.001	1.004 (1.003–1.005)
Very low density lipoprotein (VLDL) (mg/dL)	39,378	20.6 ± 11.2	0.091	<0.001	1.060 (1.052–1.068)	0.062	<0.001	1.024 (1.020–1.028)
Non-HDL cholesterol (mg/dL)	21,410	129.9 ± 35.3	0.124	<0.001	1.026 (1.022–1.029)	0.061	<0.001	1.007 (1.005–1.008)